Abstract
Introduction
Induction of anesthesia is considered critical as Laryngoscopy and endotracheal intubation elicit unwanted cardiovascular responses such as hypertension, tachycardia, dysrhythmias 1,2, and cardiovascular collapse considered as threatening complications .Hence It is desirable to use a safe inducing agent with fewer adverse effects for safety of patients.
Propofol, 2,6-diisopropylphenol is popular induction agent having rapid and smooth induction and recovery with decrease incidence of nausea and vomiting etc, 3, 4 while hypotension, dose dependent depression of ventilation, pain on Injection are the major drawbacks. 5, 6 Etomidate, a carboxylated imidazole is characterized by hemodynamic stability, minimal respiratory depression and cerebral protective effects. Its lack of effect on sympathetic nervous www.jmscr.igmpublication.org Index Copernicus Value: 79.54 ISSN (e)-2347-176x ISSN (p) 2455-0450 DOI: https://dx.doi.org/10.18535/jmscr/v7i4.68 system, baroreceptor reflex regulatory system and its effect of increased coronary perfusion even on patients with moderate cardiac dysfunction makes it an induction agent of choice in cardiac disease patients; 7 though thrombophlebitis and myoclonus are some adverse effects. 8 .
Functional Endoscopic Sinus Surgery (FESS) is a minimal invasive surgical procedure which uses nasal endoscopes to enlarge the nasal drainage pathways of the paranasal sinuses to improve sinus ventilation. These surgeries are carried out under general anaesthesia requiring blood less field and hemodynamic stability. A study was tailored to evaluate the haemodynamic effects of Propofol and Etomidate in Functional Endoscopic Sinus Surgeries (FESS) and change in blood pressure and heart rate during induction and during intubation being primary objective while pain on Injection, myoclonic movements, post-operative nausea and vomiting were compared as secondary objective. Table 1 shows that the baseline pulse rate was comparable between the two groups. In group P there was increase in mean pulse rate at intubation : T2 (106.87±11.482) followed by decrease till end of surgery T10 (78.83±7.212) which was significant statistically. (p=0.002) In group E, there was increase in mean pulse rate at intubation: T2 (92.70±10.911) followed by slight decrease till end of surgery T10 (85.97±9.922) which was statistically significant. (p=0.002). At laryngoscopy, the increase was more in Group P (106.87±11.482) as compared to Group E (92.70±10.911). After laryngoscopy, a decrease in mean HR was found which was more in Group P (78.83±7.212) than in Group E (85.97±9.922). Table 5 shows there was pain during induction in 10 (33.33%) patients in Group P. In group E, myoclonus was seen in 2 (6.67%) patients. These values were not statistically significant. (p >0.05).
Aims and Objectives

Discussion
Laryngoscopy and tracheal intubation provoke transient but marked sympathoadrenal response leading to hypertension and tachycardia though transitory and variable and may not be significant in otherwise normal individuals but is potentially harmful in cardiovascular compromised patients 9 .
In our study we observed increase in mean pulse rate at laryngoscopy from 89.90 to 106.87 followed by statistically significant decrease in rate till end of surgery in Grp P (p=0.002).Where as in Grp E there was rise in mean pulse rate at laryngoscopy from 87.03 to 92.70 followed by fall to 85.97.The variation was more with Propofol indicating better stability with Etomidate. Our results were similar to studies done by, Shagun Bhatia Shah 10 et al and Supriya Aggarwal et al 11 They used Inj. Propofol 2mg/kg and Inj. Etomidate 0.3mg/kg in a comparative study and noted that an increase in heart rate was more from baseline in Propofol group than Etomidate group at induction (p<0.05). The baseline mean systolic BP (SBP) in Group P (T0) was 115.70 with significant fall after intubation T3 (105.33) till 30 mins after intubation T9 (110.33) (p= 0.02) In Group E, the baseline mean SBP at T0 was 116.40. There was statistically significant increase in mean SBP at T2 (129.53), T3 (125.47) and 1 minute after intubation T4 (123.10) followed by negligible decrease in mean at T10 (116.13). Whereas the baseline mean diastolic BP (DBP) in Group P (T0) was 75.23. There was significant fall till 30 mins after intubation T10 (66.03) (p= 0.003). In Group E, the baseline mean DBP (T0) was 72.20. An increase in mean DBP at T2 (84.47), at T3 (80.53), T4 (78.13), T5 (76.17) and T6(74.60) was seen. Thereafter no significant change was observed. Thus, there was significant fall in DBP in Group P as compared to Group E and the decrease was statistically significant. (p= 0.003) In Group P, the baseline MAP (T0) was 87.67. with statistically significant decrease till end of surgery T10 (81.33) (p=0.008).In Group E, the baseline mean MAP (T0) was 86. The results of the present study should encourage the routine use of Etomidate as an Induction agent in patients undergoing general anaesthesia, by providing Improved haemodynamics and fewer side effects.
Conclusion
It can be concluded from above conducted study that IV Etomidate is a better induction agent than IV Propofol being more stable hemodynamically with minimal effects on heart rate, systemic blood pressure, diastolic blood pressure and mean arterial pressure. IV Etomidate causes no pain on Injection when compared with IV Propofol. Minimal side effects like myoclonus are observed with Etomidate which can be avoided by benzodiazepines and/or opioid when given as premedication. However, the study has to be done on a larger population and in high risk patients for further evaluation.
